肝移植术后人类微小病毒B19感染致骨髓抑制1例报告

高禄化; 彭梅娟; 聂青和; 王媛媛

doi:10.3969/j.issn.1001-5256.2020.05.038

肝移植术后人类微小病毒B19感染致骨髓抑制1例报告

DOI: 10.3969/j.issn.1001-5256.2020.05.038

空军军医大学唐都医院传染病科全军感染病诊疗中心

详细信息

中图分类号: R657.3;R511
计量
- 文章访问数: 815
- HTML全文浏览量: 36
- PDF下载量: 149
- 被引次数: 0
出版历程
- 出版日期: 2020-05-20

Myelosuppression induced by human parvovirus B19 infection after liver transplantation: A case report

The Center of Diagnosis and Treatment for Infectious Diseases of PLA, Department of Infectious Diseases, Tangdu Hospital, Air Force Medical University, Xi’an 710038, China

摘要

摘要:
<正>人类微小病毒（human parvovirus, HPV）B19是一种单链小DNA病毒,与人类多种疾病相关。该病毒感染正常免疫力人群只会出现短暂病变,临床表现与宿主的年龄和免疫状态有关,感染后主要侵袭人体造血系统,可表现为骨髓抑制,也会发生发热、皮疹和关节痛多种并发症等[1]。但对于移植术后的免疫抑制人群,HPV B19感染发病率较高,可引起急性骨髓造血衰
- 肝移植 /
- 细小病毒B19,人 /
- 骨髓疾病
- liver transplantation /
- parvovirus B19,human /
- bone marrow diseases

HTML全文

参考文献(10)

[1] SHAO HX. Recent research progress in human parvovirus B19infection[J]. Med Recapitulate, 2011, 17(20):3063-3066.(in Chinese）邵惠训．人类微小病毒B19感染的最新进展[J]．医学综述，2011, 17(20):3063-3066.

[2] CORCORAN C, HARDIE D, YEATS J, et al. Genetic variants of human parvovirus B19 in South Africa:Cocirculation of three genotypes and identification of a novel subtype of genotype 1[J]. J Clin Microbiol, 2010, 48(1):137-142.

[3] JIANG M, LUO CB, ZHAN H, et al. Clinical characteristic analysis on anemia associated with human parvovirus B19 infection in liver transplant recipients[J]. Chin J Clin Med, 2018,25(3):405-408.(in Chinese）蒋密，罗楚彬，战昊，等．肝移植患者人类微小病毒B19感染与相关贫血的临床特点分析[J]．中国临床医学，2018, 25(3):405-408.

[4] ABDOLLAHI A, SHOAR S, SHEIKHBAHAEI S, et al. Status of immunity against PVB19 in HIV-infected patients according to CD4(+)cel count, and antiretroviral therapy regimen groups[J].Niger Med J, 2014, 55(1):20-23.

[5] HUANG SL, YU LX, DENG WF, et al. Pure red cell aplasia caused by human parvovirus B19 infection after renal transplantation:A report of 2 cases and literature review[J]. Ogran Transplantation, 2015, 6(4):249-253.(in Chinese）黄森林，于立新，邓文锋，等．肾移植术后人类微小病毒B19感染致纯红细胞再生障碍性贫血2例并文献复习[J]．器官移植，2015, 6(4):249-253.

[6] LI SY, SHEN B, LIU ZH, et al. Human parvovirus B 19-induced pure red cell aplasia in patients with al ograft renal transplantation[J]. Prog Mod Biomed, 2012, 12(14):2698-2702.(in Chinese）李帅阳，沈兵，刘志宏，等．肾移植术后人微小病毒B19感染导致纯红细胞增生障碍性贫血[J]．现代生物医学进展，2012, 12(14):2698-2702.

[7] XIE EB, XUAN FH, SUN XD, et al. An analysis of risk factors for early complications after liver transplantation[J]. J Clin Hepatol, 2018, 34(6):1282-1288.(in Chinese）解恩博，轩凤慧，孙晓东，等．肝移植术后早期并发症的危险因素分析[J]．临床肝胆病杂志，2018, 34(6):1282-1288.

[8] CHEN T, LI RD, YING Y, et al. Next generation sequencing screening for human parvovirus B19 infection after liver transplantation and the analysis of related risk factors[J]. Ogran Transplantation, 2019, 10(6):696-701.(in Chinese）陈拓，李瑞东，应悦，等．肝移植术后人类细小病毒B19感染的二代测序筛查及其相关危险因素分析[J]．器官移植，2019, 10(6):696-701.

[9] LI DL, LIANG TB. Etiology and diagnosis and treatment of pure red cell aplasia after solid organ transplantation[J]. Natl Med J China, 2006, 86(42):3020-3022.(in Chinese）李栋林，梁廷波．实体器官移植后纯红细胞再生障碍性贫血的病因与诊治[J]．中华医学杂志，2006, 86(42):3020-3022.

[10] CRABOL Y, TERRIER B, ROZENBERG F, et al. Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection:A retrospective study of 10 patients and review of the literature[J]. Clin Infect Dis, 2013, 56(7):968-977.

施引文献

资源附件(0)

访问统计